about
Roles and practices of general practitioners and psychiatrists in management of depression in the communityPharmacoepidemiology studies: what levels of evidence and how can they be reached?Liver transplant associated with paracetamol overdose: results from the seven-country SALT studyHospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.[Who are patients suffering from bipolar disorders in France? The TEMPPO survey: patients' sociodemographic and clinical characteristics data].The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study.Agrobacterium uses a unique ligand-binding mode for trapping opines and acquiring a competitive advantage in the niche construction on plant host.Population genomics reveals additive and replacing horizontal gene transfers in the emerging pathogen Dickeya solani.A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine.A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC.The CADEUS study: methods and logistics.The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers.Complete genome anatomy of the emerging potato pathogen Dickeya solani type strain IPO 2222T.Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.Administrative complexities for a European observational study despite directives harmonising requirements.Use of health insurance claim patterns to identify patients using nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC.Antihypertensive drugs, hypotension, and ischemic colitis.Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies.Outcomes following acute hospitalised myocardial infarction in France: An insurance claims database analysis.Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database.Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study.Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.Usage patterns of paracetamol in France.High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients.Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database.Survey of the therapeutic management of rheumatoid arthritis in France: the OPALE study.Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database.[Infections by Candida sp. in intensive care. Survey of French practices].[Compliance with hormone replacement therapy in menopausal women: results of a two-year prospective French study comparing transdermal treatment with fixed oral combination therapy]Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France.Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov model.[Cohort study of treated or not treated depressive workers: methodology and preliminary results][Evaluation of tolerance during intravenous administration of low dose of isosorbide dinitrate in the treatment of unstable angina]Is paracetamol hepatotoxic at normal doses?Evaluation of the protective effect of BCG vaccination by a case-control study in Yaounde, Cameroon.Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.Impact of prescriber nonresponse on patient representativeness.[Neuroleptic drug utilization among schizophrenic outpatients].
P50
Q25257809-BCE212AE-CADE-4F89-9F8C-DB3FF92691D4Q27021654-62FC48BF-01AA-4CA4-AB3C-645158B212F4Q28607494-2F6E1881-3E41-4FDD-A844-2613AAF1F864Q33692833-EFF60BDD-7745-45E7-A744-E7E1085ADDC9Q34314928-D4E0652E-1563-4E77-BC4A-26FC3D70106DQ34476131-F61084F2-C5C9-4622-B3DA-B81EF506F86BQ34565386-29B829B8-168E-4CBD-BFB4-064BC1540CD9Q35316943-20C08D04-5588-48CF-84F7-3F67F059E251Q35807380-6EE3B692-2AB9-4403-AFD3-A1D7A397AB7AQ36445386-6D9BC7DA-4005-4176-B358-9D72F60CF78BQ36618123-0C229969-26B7-4656-9F62-91730AFF0C91Q36661111-64197E92-A54D-431B-800C-578096D0A7A4Q37156300-E564BC3D-6144-46D7-B065-7BA3048F345AQ37450320-485C9D8F-63BC-49C6-AC76-71F71DBE6D92Q37731873-2BA2186C-1233-46DA-8232-3935AB22F4FEQ37984214-7423DB12-2628-47DB-BAC6-0D15E5E9CD2EQ37984219-2A090683-6D0D-4BAD-AA41-3D8889AF8432Q38164425-98C4DF83-B294-4F7B-A23F-978849C4BD13Q38378910-10418273-BED3-40FD-8B51-E2CF66D9691DQ38833125-837074F7-92F3-416F-86A0-BB389CC393DFQ39636428-540727E8-2618-45EA-AE15-D3F48D8F960FQ40272818-02FB29E6-4018-4F8E-B6C6-1F954AAD6E6BQ40273819-1332B17A-E079-4DEF-A388-E57A9B906EB8Q42162410-0CF2F16D-3693-41AF-BD06-C59426F8BE83Q42382870-F3F75206-61BE-4A48-83B9-F0F6C191F0B5Q42851862-2BA26A3A-6B96-4C28-A5A5-1D411645E619Q43858864-CE428B55-2200-4FEA-A0DA-F53ED823E3D9Q44016892-BE7D8D08-950D-4D18-B382-2771E342AC1AQ44061441-1D3B30BE-04DA-46AC-BA33-09453BA3BD87Q44431391-BEF08E63-F40A-40A1-B8F0-6F631F08ECABQ44514475-3034C59D-F8CD-4EA6-8539-A28F4A2A3DF4Q44771754-3A9BE6D9-6E6A-4B2E-BAA8-51826BF9A7F0Q45031879-A7757FD1-8117-4B48-B394-A89584CCEA5FQ45070419-42387221-58F0-493B-B1B2-5E3C87B7DDD3Q46009347-42A20F72-5204-4BC1-A02E-5E4A86F60A4FQ46373677-3D7D5C63-4644-4AE8-85EE-1C64F96AC13BQ46633956-C7B4304C-984A-44EC-A773-13F667BE1978Q46675145-FA230806-673C-48A4-98BB-5ED4138A0545Q46733060-56308F40-D020-417B-B485-C04B699439A7Q46910404-CE54A1DC-5F05-45D0-B7E6-F9628F162DE5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patrick Blin
@ast
Patrick Blin
@en
Patrick Blin
@es
Patrick Blin
@nl
Patrick Blin
@sl
type
label
Patrick Blin
@ast
Patrick Blin
@en
Patrick Blin
@es
Patrick Blin
@nl
Patrick Blin
@sl
prefLabel
Patrick Blin
@ast
Patrick Blin
@en
Patrick Blin
@es
Patrick Blin
@nl
Patrick Blin
@sl
P106
P21
P31
P496
0000-0003-4005-7928